JY
OKYO

Jeff Yass’s OKYO Pharma OKYO Stock Holding History

Jeff Yass’s Portfolio OKYO Stock Details OKYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,123
Closed -$13.6K – 12730
2024
Q2 		$13.6K Sell
11,123
-9,187
-45% -$12.9K ﹤0.01% 11732
2024
Q1 		$30.5K Sell
20,310
-14,474
-42% -$22.2K ﹤0.01% 11715
2023
Q4 		$61.9K Buy
+34,784
New +$61.1K ﹤0.01% 11621

Other funds holding OKYO

Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CA
Continuum Advisory Eagle, Idaho $1.24B AUM 30.12% 1-Year Est. Return

Jeff Yass's OKYO Position: Q3 2024 in Review

Jeff Yass sold out of OKYO Pharma (OKYO) in Q3 2024, closing a stake of 11,123 shares — an estimated $13.6K sold.

Jeff Yass first reported a position in OKYO in Q4 2023 and held it in 3 quarters. The position peaked at $61.9K in Q4 2023. 6 funds tracked by Wall St. Rank hold OKYO as of Q3 2024.

  • Jeff Yass reported no remaining OKYO Pharma position as of Q3 2024 after selling out during the quarter.
  • Jeff Yass sold 11,123 OKYO Pharma shares in Q3 2024, an estimated $13.6K.
  • Jeff Yass first reported a position in OKYO Pharma in Q4 2023 and held it in 3 quarters.
  • Jeff Yass's OKYO Pharma position peaked at $61.9K in Q4 2023.
  • 6 funds tracked by Wall St. Rank held OKYO Pharma as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.